What new treatments for Appendiceal Cancer are being developed in 2026

New and Emerging Treatments for Appendiceal Cancer in 2026

Based on the most current NCCN Guidelines (Version 1.2026), I can share what's available and being explored for appendiceal cancer treatment. However, I should note that the guidelines I have access to focus primarily on established treatment approaches rather than brand-new 2026 developments. Let me explain what's currently standard and what's on the horizon.

Current Standard Treatments (2026)

According to the NCCN Guidelines for Appendiceal Neoplasms and Cancers, the main treatment approaches include:

For Localized Disease:

• Surgery (appendectomy or right hemicolectomy) - remains the foundation of treatment
• Adjuvant chemotherapy for higher-risk cases, typically using regimens like FOLFOX or CAPEOX (combinations of fluorouracil, leucovorin, and oxaliplatin)

For Peritoneal Disease (spread within the abdomen):

• Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - this is a specialized approach where chemotherapy is heated and delivered directly into the abdominal cavity during surgery
• Mitomycin C is the most commonly used agent for HIPEC, though oxaliplatin is an alternative option

For Metastatic Disease:

The NCCN Guidelines recommend chemotherapy regimens similar to colorectal cancer, including:

• FOLFOX or CAPEOX (preferred initial therapies)
• FOLFIRI (fluorouracil, leucovorin, and irinotecan)
• Capecitabine alone or with bevacizumab (an anti-angiogenesis drug that cuts off blood supply to tumors)

Emerging and Biomarker-Directed Approaches

For patients with specific genetic mutations, targeted therapies are available:

BRAF V600E mutations:

• Encorafenib combined with cetuximab or panitumumab

KRAS G12C mutations:

• Adagrasib or sotorasib combined with cetuximab or panitumumab

HER2-positive tumors:

• Pertuzumab or tucatinib combined with trastuzumab
• Fam-trastuzumab deruxtecan (for HER2 3+ tumors)

Mismatch Repair Deficiency (dMMR) or Microsatellite Instability (MSI-H):

• Immunotherapy options including:
  • Pembrolizumab
  • Nivolumab
  • Dostarlimab
  • Ipilimumab + nivolumab combinations

These immunotherapies work by helping your immune system recognize and attack cancer cells.

Important Context About Appendiceal Cancer Treatment

According to NCCN Guidelines, the histologic subtype (the specific type of appendiceal cancer) is critically important because different types respond differently to treatment:

• LAMN/HAMN (low-grade and high-grade mucinous neoplasms) - often managed with surgery and CRS/HIPEC rather than systemic chemotherapy
• AA/GCA/UC-NOS (adenocarcinoma, goblet cell carcinoma, and undifferentiated carcinomas) - typically treated with chemotherapy similar to colorectal cancer

What You Should Ask Your Oncology Team

Since appendiceal cancer is rare and treatment is highly individualized, I recommend asking your care team:

1. "What is the specific histologic type and stage of my appendiceal cancer?" - This determines which treatment approaches are most appropriate.

2. "Has my tumor been tested for genetic mutations (BRAF, KRAS, HER2, MSI-H/dMMR)?" - These results may open access to targeted or immunotherapy options.

3. "Am I a candidate for CRS/HIPEC, and if so, would you recommend it?" - This specialized surgery requires experienced peritoneal surface malignancy surgeons.

4. "Are there clinical trials available for my specific cancer type and stage?" - Clinical trials often provide access to newer treatment combinations before they're widely available.

5. "What is the treatment plan if my cancer progresses on the initial therapy?" - Understanding second-line and subsequent options helps with planning.

Finding the Latest Information

For the most current information on emerging treatments and clinical trials:

• NCCN.org - Updated guidelines (what I referenced above)
• ClinicalTrials.gov - Search for "appendiceal cancer" to find active trials
• American Cancer Society - Patient-friendly information on appendiceal cancer
• Appendiceal Cancer Awareness and similar advocacy organizations - Often have current treatment information

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.